Ultime notizie per Metagenomi (NASDAQ:MGX) Azioni

Metagenomi

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Metagenomi Inc

MGX Minerals Inc

Morgan Stanley analyst Joseph Moore maintains NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) with a Equal-Weight and lowers the price target from $250 to $235.

News

Price Target

Analyst Ratings

NXPI

Morgan Stanley Maintains Equal-Weight on NXP Semiconductors, Lowers Price Target to $235

Needham analyst Gil Blum reiterates TScan Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) with a Buy and maintains $11 price target.

Reiteration

TCRX

Needham Reiterates Buy on TScan Therapeutics, Maintains $11 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) with a Buy and maintains $32 price target.

IOVA

HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target

HC Wainwright &amp; Co. analyst Emily Bodnar maintains Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) with a Buy and raises the price target from $80 to $95.

ACLX

HC Wainwright & Co. Maintains Buy on Arcellx, Raises Price Target to $95

Deutsche Bank analyst David Begleiter upgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Hold to Buy and lowers the price target from $135 to $110.

Upgrades

Deutsche Bank Upgrades Celanese to Buy, Lowers Price Target to $110

HC Wainwright &amp; Co. analyst Edward White reiterates Karyopharm Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) with a Buy and maintains $7 price target.

KPTI

HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $7 Price Target

Needham analyst Mike Matson reiterates NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) with a Buy and maintains $19 price target.

Needham Reiterates Buy on NeoGenomics, Maintains $19 Price Target

Needham analyst Gil Blum reiterates Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) with a Buy and maintains $96 price target.

Needham Reiterates Buy on Arcellx, Maintains $96 Price Target

Deutsche Bank analyst Nicole Deblase maintains Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) with a Buy and raises the price target from $136 to $140.

Deutsche Bank Maintains Buy on Emerson Electric, Raises Price Target to $140

KRKR

36kr Holdings Inc. Announced That It Has Recently Teamed Up With Soften Corporation To Launch An Innovative News Hub, The "36kr Market Watch" Wechat Mini Program

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Arcus Biosciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>) with a Neutral and maintains $20 price target.

RCUS

HC Wainwright & Co. Reiterates Neutral on Arcus Biosciences, Maintains $20 Price Target

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are up by over 13% in pre-market trading on Wednesday over a likely Donald Trump victory in the <a href="https://www.benzinga.com/topic/2024-election" target="_blank" rel="noreferrer noopener">U.S. Presidential elections</a>.
What Happened: According <a href="https://www.nytimes.com/live/2024/11/05/us/trump-harris-election" target="_blank" rel="noreferrer noopener">to</a> The New York Times, Trump currently has over 95% chance of victory given he already has <a href="https://www.benzinga.com/news/24/11/41766547/trump-gives-victory-speech-in-florida-as-winning-pennsylvania-puts-him-at-brink-of-victory-vows-to-f" target="_blank" rel="noreferrer noopener">267 of the 270 electoral votes needed to win</a>.
At the time of writing, the Tesla stock was up 13.3% in premarket trading, at $284.90, according to <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Tesla CEO&nbsp;Elon Musk&nbsp;endorsed Trump in July and has been actively campaigning for the former President&nbsp;<a href="https://www.benzinga.com/news/24/11/41709658/stephen-king-slams-elon-musk-claims-most-of-his-posts-spread-pro-trump-disinformation-and-outright-l" target="_blank" rel="noreferrer noopener">both offline and online</a>. Musk even campaigned for Trump in the swing state of Pennsylvania in October.
Trump, meanwhile, has expressed his intent to set up a&nbsp;<a href="https://www.benzinga.com/government/24/09/40739165/trump-plans-to-appoint-elon-musk-to-government-efficiency-commission-if-elected-tesla-ceo-says-hell" target="_blank" rel="noreferrer noopener">government efficiency commission</a>&nbsp;led by Musk if elected President. The commission will be tasked with conducting a complete financial and performance audit of the federal government and recommending reforms, Trump said in September.
According to&nbsp;Wedbush&nbsp;analyst&nbsp;Dan Ives, the&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41766869/trump-win-biggest-positive-for-elon-musks-tesla-tech-bull-says-it-could-boost-ev-gi" target="_blank" rel="noreferrer noopener">biggest positive from a Trump win would be for Tesla and Musk</a>.
"We believe a Trump win is a negative for the EV industry as the EV rebates/tax incentives get pulled, however for Tesla a huge positive for scale/price advantage," Ives said on Wednesday. The analyst added that a Trump win could add $40-$50 to Tesla's stock.
Tesla&#8217;s Frankfurt-listed shares are also up by over 14.5%.
Price Action: Year-to-date, Tesla shares are up 1.2%, after the stock closed up 3.5% at $251.44 on Tuesday, according to <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41738613/elon-musk-rejects-rumors-of-a-tesla-phone-but-says-the-ev-giant-will-have-to-make-one-if-this-happen" target="_blank" rel="noreferrer noopener">Elon Musk Rejects Rumors Of A Tesla Phone, But Says The EV Giant Will Have To Make One If This Happens</a></li>
</ul>
Photo courtesy: Tesla

Equities

WIIM

Pre-Market Outlook

Markets

Tech

TSLA

Tesla Stock Surges Over 13% In Premarket: What Is Going On

Needham analyst Joseph Stringer maintains Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Buy and lowers the price target from $85 to $60.

APLS

Needham Maintains Buy on Apellis Pharmaceuticals, Lowers Price Target to $60

Needham analyst Mayank Tandon maintains Payoneer Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) with a Buy and raises the price target from $10 to $14.

PAYO

Needham Maintains Buy on Payoneer Global, Raises Price Target to $14

HC Wainwright &amp; Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDTX#NASDAQ">BDTX</a>) with a Buy and maintains $11 price target.

BDTX

HC Wainwright & Co. Reiterates Buy on Black Diamond Therapeutic, Maintains $11 Price Target

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has redefined the way users can <a href="https://www.benzinga.com/topic/2024-election">track election results</a>, providing live updates directly on the lock screens of iPhones and iPads.
What Happened: On election day in the U.S., Apple News rolled out a feature that enabled users to monitor the electoral count in real-time on their Dynamic Island while multitasking on their devices.
Users can access this feature by registering on Apple News and following the &#8220;2024 election live&#8221; banner.
If the option isn&#8217;t immediately visible, it can be found under &#8220;Election 2024&#8221; in the &#8220;Special Coverage&#8221; section of the menu. Once enabled, users will receive a notification confirming the activation of the Live Activity.
See Also:&nbsp;<a href="https://www.benzinga.com/news/large-cap/24/11/41703422/google-delivers-new-ai-features-to-maps-google-earth-waze-apps?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Google Delivers New AI Features To Maps, Google Earth, Waze Apps</a>
The&nbsp;widgets were available on&nbsp;iPhones, iPads, and Apple Watches&nbsp;as&nbsp;the U.S. presidential and congressional&nbsp;election votes were counted on Tuesday night. It displayed&nbsp;the electoral count for Donald&nbsp;Trump and Kamala Harris, along with&nbsp;Senate and House election results.
The new feature has been well-received on social media, with one user stating it&#8217;s&nbsp;&#8220;exactly what the ghost of&nbsp;Steve Jobs intended the Dynamic Island be used for.&#8221;
Here&#8217;s how people reacted to the feature on X, formerly Twitter:
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">exactly what the ghost of Steve Jobs intended the Dyamnic Island be used for <a href="https://t.co/nl2ZG6KvZp">pic.twitter.com/nl2ZG6KvZp</a>
&mdash; Alex Heath (@alexeheath) <a href="https://twitter.com/alexeheath/status/1853947230887276826?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Election results baked right into the Dynamic Island??? Nicely done, <a href="https://twitter.com/Apple?ref_src=twsrc%5Etfw">@Apple</a>. <a href="https://t.co/6acnb1eP4m">pic.twitter.com/6acnb1eP4m</a>
&mdash; Parker Ehret (@parkerehret) <a href="https://twitter.com/parkerehret/status/1853937235458224582?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Gotta admit, this is a REALLY clever use of the Dynamic Island by Apple News. <a href="https://t.co/y5eA2RT4je">pic.twitter.com/y5eA2RT4je</a>
&mdash; Shannon Potter (@cifilter) <a href="https://twitter.com/cifilter/status/1853936196847874318?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
However, some users complained that the feature crashed in the middle of the voting count, and stopped providing the latest updates.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">And just like that…. Apple News stops their election updates. &#x1f923;&#x1f923;&#x1f923;&#x1f923; <a href="https://t.co/W6XcfCHf5v">pic.twitter.com/W6XcfCHf5v</a>
&mdash; A Nobody (@N047201) <a href="https://twitter.com/N047201/status/1854056352982642784?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Why did the Apple News election live activity just die?
&mdash; Bella (@b3lla_dev) <a href="https://twitter.com/b3lla_dev/status/1854056390517481948?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">APPLE HAS CALLED THE ELECTION WITH NO WINNER <a href="https://t.co/2XkSoBTsOL">pic.twitter.com/2XkSoBTsOL</a>
&mdash; jade (@nothingneko_) <a href="https://twitter.com/nothingneko_/status/1854056939908415492?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The election day has resulted in <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41765518/5-things-moving-as-trump-trade-fever-sweeps-wall-street-amid-election-night-drama">significant movements</a> across Wall Street and a surge in the shares of Trump's media company, Trump Media &amp; Technology Group Corp.
The election night also saw a rise in stock futures and&nbsp;<a href="https://www.benzinga.com/news/24/11/41765345/treasury-yields-pop-on-trump-victory-chances-10-year-benchmark-reaches-4-month-high">yields on U.S. sovereign debt</a>.
As the election progressed, former President Trump&nbsp;<a href="https://www.benzinga.com/news/24/11/41766547/trump-gives-victory-speech-in-florida-as-winning-pennsylvania-puts-him-at-brink-of-victory-vows-to-f">declared victory</a>&nbsp;after winning key battleground states.
While addressing his supporters in New York, Trump stated, &#8220;I want to thank the American people for the extraordinary honor of being elected your 47th president and your 45th president.&#8221;
At the time of writing, the latest <a href="https://apnews.com/live/trump-harris-election-updates-11-5-2024">data</a> from the Associated Press showed that Trump secured 267 of the 270 electoral votes required for a win. The Republican Party is also leading in crucial states like Michigan and Wisconsin, which have yet to be decided.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41738613/elon-musk-rejects-rumors-of-a-tesla-phone-but-says-the-ev-giant-will-have-to-make-one-if-this-happen?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Rejects Rumors Of A Tesla Phone, But Says The EV Giant Will Have To Make One If This Happens</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Apple

Politics

AAPL

Trump Vs. Harris: Apple Transforms Dynamic Island To Bring Election Results At Your Fingertips On iPhone

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) with a Buy and maintains $22 price target.

STOK

Needham Reiterates Buy on Stoke Therapeutics, Maintains $22 Price Target

Macro Economic Events

Econ #s

Economics

S&P Global / CIPS UK Construction Purchasing Managers Index For October 54.3 Vs. 55.3 Est.; 57.2 Prior

HCOB Eurozone Services Purchasing Managers Index For October 51.6 Vs. 51.2 Est.; 51.4 Prior

HCOB Eurozone Composite Purchasing Managers Index For October 50.0 Vs. 49.7 Est.; 49.6 Prior

Companies in the NA sector have received a lot of coverage today as analysts weigh in on Metagenomi, Inc. (MGX – Research Report) and Smith Douglas...

Analysts Offer Insights on NA Companies: Metagenomi, Inc. (MGX) and Smith Douglas Homes Corp. Class A (SDHC)

Metagenomi, Inc. GAAP EPS of -$0.29, revenue of $20M

In a report released yesterday, Geulah Livshits from Chardan Capital maintained a Buy rating on Metagenomi, Inc. (MGX – Research Report), with a pr...

Buy Rating Affirmed for Metagenomi Amid Strong Financials and Promising Gene Therapy Research

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Metagenomi, Inc. (MGX – Research Report) yesterday and set a price target of $7....

Metagenomi, Inc. Maintains Buy Rating Amidst Competitive Challenges and Strong Financial Outlook

Wells Fargo analyst Yanan Zhu has maintained their bullish stance on MGX stock, giving a Buy rating on August 21. Yanan Zhu has given his Buy ratin...

Buy Rating Justified by Metagenomi's Breakthrough in Long-term Gene Therapy Efficacy and Safety

Kostas Biliouris, an analyst from BMO Capital, maintained the Buy rating on Metagenomi, Inc. (MGX – Research Report). The associated price target r...

Buy Rating Justified by Metagenomi's Promising Gene Therapy and Strategic Market Positioning in Hemophilia A Treatment

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Metagenomi, Inc. (MGX – Research Report) and keeping the price target at $7...

Buy Rating on Metagenomi, Inc. for Promising Hemophilia A Gene Editing Strategy and Strong Financial Position

THE LAWSUIT: A class action securities lawsuit was filed against Metagenomi, Inc. (MGX) that seeks to recover losses of Metagenomi shareholders who...

Metagenomi, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – MGX

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Metagenomi, Inc. (MGX – Research Report) today and set a price target of $7.00. ...

Metagenomi's Advancements in SMART Platform and Robust Pipeline Justify Buy Rating

Metagenomi (MGX) presented a poster titled "Efficient and specific genome editing with metagenomics-derived base editor for human therapeutic appli...

Metagenomi presents poster on genome editing at ESGCT

SDHC

Legal

Press Releases

METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline

Penny Stocks

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Metagenomi, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights – MGX

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi Lawsuit - MGX

METAGENOMI (NASDAQ: MGX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action

DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Health Care

General

Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)

METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm

Comments

Metagenomi

Notizie

Ultime notizie per Metagenomi (NASDAQ:MGX) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO